A Philadelphia jury has ordered on Tuesday
Johnson & Johnson
to a man in Maryland who said that taking J & J's antipsychotic Risperdal as a child led to breast augmentation to pay $ 8 billion in compensation More than 13,000 lawsuits against J & J alleging that Risperdal has caused a condition called gynecomastia in boys, which involves enlargement of breast tissue. The complaints generally claim that J & J was aware of the risk of this side effect, but underestimated the risk to physicians.
This is also the latest in a series of costly legal setbacks for J & J in a series of lawsuits in which infringements due to products and medicines are claimed to be other claims. In August, a judge in Oklahoma called on the company to pay $ 572 million to contribute to the state's opioid addiction crisis.
Last year, a jury in St. Louis found that J & J should pay $ 4.69 billion in damages to women and their families who blamed ovarian cancers for using the company's baby powder ,
J & J has denied the allegations and tried to appeal the decisions on baby powder and opioids. Last week, J & J said it had agreed to pay $ 20.4 million to settle lawsuits filed by two Ohio counties as it contributed to the triggers of the opioid epidemic. The company gave no liability.
In appeal decisions, judges often reduce jury punitive damages sums.
The most recent judgment comes from a lawsuit by
Who said that his use of Risperdal between 2003 and 2008 caused gynecomastia. In 201
Mr. Murray's attorneys Thomas Kline and
In a statement, the jury said that "Johnson & Johnson has been strongly asserted that his actions were deliberate and malicious" US patent exclusivity in 2008.
Please call Peter Loftus at peter.loftus @ wsj.com
Copyright © 2019 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8